MA23587A1 - Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme - Google Patents

Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme

Info

Publication number
MA23587A1
MA23587A1 MA23930A MA23930A MA23587A1 MA 23587 A1 MA23587 A1 MA 23587A1 MA 23930 A MA23930 A MA 23930A MA 23930 A MA23930 A MA 23930A MA 23587 A1 MA23587 A1 MA 23587A1
Authority
MA
Morocco
Prior art keywords
nicotine
smoking
treatment
need
related syndrome
Prior art date
Application number
MA23930A
Other languages
English (en)
Inventor
Majeti Satyanarayama
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA23587A1 publication Critical patent/MA23587A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
MA23930A 1994-06-23 1995-05-16 Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme MA23587A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
MA23587A1 true MA23587A1 (fr) 1995-12-31

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23930A MA23587A1 (fr) 1994-06-23 1995-05-16 Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme

Country Status (6)

Country Link
AU (1) AU2770895A (fr)
IL (1) IL114128A0 (fr)
MA (1) MA23587A1 (fr)
PE (1) PE41096A1 (fr)
WO (1) WO1996000070A1 (fr)
ZA (1) ZA955031B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220768A1 (fr) * 1996-03-13 1997-09-18 Yale University Traitements pour cesser de fumer impliquant l'utilisation de naltrexone et de composes associes
WO1997034605A1 (fr) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Utilisation de nicotine pour traiter une hepatopathie
PL187242B1 (pl) 1996-05-13 2004-06-30 Novartis Consumer Health Sa Policzkowy układ dostarczający
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
CA2369515A1 (fr) 1999-04-06 2001-03-29 Wm. Wrigley Jr. Company Formulations pharmaceutiques de gomme a macher
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
WO2004104490A1 (fr) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Unite de chauffage autonome et unite de fourniture de medicament faisant appel a cette unite de chauffage
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
EP2121088B1 (fr) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Unité chauffante à utiliser dans un dispositif d'administration de médicament
WO2012083947A1 (fr) * 2010-12-21 2012-06-28 Fertin Pharma A/S Composition de chewing-gum comprenant du poly(acide acrylique) réticulé
MX2023002434A (es) * 2020-09-03 2023-03-22 Nicoventures Trading Ltd Composiciones y metodos.
CN115590855A (zh) * 2022-10-26 2023-01-13 江南大学（Cn） 一种降低尼古丁制品中尼古丁含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (da) * 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526A (fi) * 1990-08-23 1992-02-24 Wrigley W M Jun Co Tuggummi med laog fukthalt.

Also Published As

Publication number Publication date
PE41096A1 (es) 1996-10-08
AU2770895A (en) 1996-01-19
WO1996000070A1 (fr) 1996-01-04
IL114128A0 (en) 1995-10-31
ZA955031B (en) 1996-02-08

Similar Documents

Publication Publication Date Title
MA23587A1 (fr) Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
DE69619433D1 (de) Tabakrauchfilter und Verfahren zur Herstellung derselben
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FI950587A (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
PT836390E (pt) Cigarro e metodo para o fabrico de cigarro para sistema electrico de fumar
FR2726191B1 (fr) Dispositif de traitement du syndrome d'apnee pendant le sommeil
DE69520816D1 (de) Tabakrauchfiltermaterial und Tabakrauchfilter hergestellt aus diesem Material
DE69626920D1 (de) Tabakrauchfiltermaterial und Tabakrauchfilter hergestellt aus diesem Material
DE69003977D1 (de) Verfahren und Einrichtung zur Bestimmung des Stengelgehaltes von Tabak.
FI956339A (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminen
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
NO951175D0 (no) Sigarettfilter og fremgangsmåte for dets fremstilling
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
MA23588A1 (fr) Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
DE69715922T2 (de) Verfahren und einrichtung zur behandlung von tabak
MA23586A1 (fr) Traitement des besoins en nicotine et/ou du syndrome de manque lie au tabagisme
DE69306328T2 (de) Einrichtung zum automatischen Rauchen von Tabakrollen und zum Analysieren des Rauches
BR9001661A (pt) Artigo para fumantes e tratamento de tabaco
ITMI931359A0 (it) Procedimento e dispositivo per l'essiccamento di tabacco
FI972055A (fi) Syljen analysointimenetelmä
BR9507375A (pt) Tratamento de superficies particuladas
FR2718978B1 (fr) Composition microgranulée adsorbante et absorbante pour cendriers et procédé pour sa préparation.
FR2748907B3 (fr) Utilisation des galles et derives galliques dans la fabrication des cigarettes et le traitement des tabacs
ID16159A (id) Komposisi dan metode untuk mengobati gangguan pernafasan
NO942611D0 (no) Anvendelse av nikotin og innretning for inhalering av nikotin